In conclusion, this report demonstrates that some TAZ mutations do not result in profound CL4 deficiency and highlights the importance of measurement of MLCL/CL4 rather than CL4 alone in the biochemical diagnosis of BTHS. This evidence concerns the gene TAFAZZIN and hyperinsulinemic hypoglycemia, familial, 4.